CFD
EGRX

Creative Financial Designs’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Creative Financial Designs’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-165
Closed -$7K – 1312
2020
Q3 		$7K Buy
+165
New +$7.22K ﹤0.01% 882

Other funds holding EGRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Creative Financial Designs's EGRX Position: Q4 2020 in Review

Creative Financial Designs sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2020, closing a stake of 165 shares — an estimated $7K sold.

Creative Financial Designs first reported a position in EGRX in Q3 2020 and held it in 1 quarter. The position peaked at $7K in Q3 2020. 166 funds tracked by Wall St. Rank hold EGRX as of Q4 2020.

  • Creative Financial Designs reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Creative Financial Designs sold 165 Eagle Pharmaceuticals, Inc. shares in Q4 2020, an estimated $7K.
  • Creative Financial Designs first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Creative Financial Designs's Eagle Pharmaceuticals, Inc. position peaked at $7K in Q3 2020.
  • 166 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2020.

Based on Creative Financial Designs's 13F filing for Q4 2020, filed 8 Jan 2021.